Christian Quaade
Geen lopende functies
Profiel
Dr. Christian Quaade is a Research Analyst at JB Capital Markets Sociedad de Valores SA.
He was previously employed as a Manager by Interface Biotech A and a Manager by NsGene A.
He also served on the board at NatImmune A.
Dr. Quaade received his undergraduate degree from the University of Copenhagen, a graduate degree from the Technical University of Denmark, and a doctorate degree from the University of Texas.
Eerdere bekende functies van Christian Quaade
| Bedrijven | Functie | Einde |
|---|---|---|
JB Capital Markets Sociedad de Valores SA
 JB Capital Markets Sociedad de Valores SA Investment Banks/BrokersFinance JB Capital Markets Sociedad de Valores SA (JB Capital Markets) is a broker/dealer firm headquartered in Madrid, Spain. The firm was founded by Javier Botín in 2008 and formerly known as M&B Capital Markets Sociedad de Valores SA. JB Capital Markets offers brokerage and advisory services to a wide base of institutional investors. | Analyst-Equity | 01-02-2013 |
Interface Biotech A/S
 Interface Biotech A/S Pharmaceuticals: MajorHealth Technology Interface Biotech A/S develops products for the treatment of cartilage and bone disorders. The firm also offers cGMP culturing of human cells for implantation and research services. The company was founded in 1998 by Kurt Osther and is headquartered in Hoersholm, Denmark. | Corporate Officer/Principal | - |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Public Communications Contact | - |
Opleiding van Christian Quaade
| University of Copenhagen | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
| Technical University of Denmark | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Health Technology |
Interface Biotech A/S
Interface Biotech A/S Pharmaceuticals: MajorHealth Technology Interface Biotech A/S develops products for the treatment of cartilage and bone disorders. The firm also offers cGMP culturing of human cells for implantation and research services. The company was founded in 1998 by Kurt Osther and is headquartered in Hoersholm, Denmark. | Health Technology |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
JB Capital Markets Sociedad de Valores SA
JB Capital Markets Sociedad de Valores SA Investment Banks/BrokersFinance JB Capital Markets Sociedad de Valores SA (JB Capital Markets) is a broker/dealer firm headquartered in Madrid, Spain. The firm was founded by Javier Botín in 2008 and formerly known as M&B Capital Markets Sociedad de Valores SA. JB Capital Markets offers brokerage and advisory services to a wide base of institutional investors. | Finance |
